Find Academic Supervisors

Bogdan V IsailaView profile

Assistant Professor

• Genitourinary Pathology
• Soft Tissue Pathology
• Cytopathology
• +5 more

Bogdan V Isaila, MD serves as Assistant Professor in Pathology at Northwestern University's Feinberg School of Medicine, specializing in Genitourinary Pathology and Soft Tissue Pathology. His educational credentials include: MD from Universitatea de Medicina si Farmacie “Grigore T. Popa”, Iasi (2000) Residency in Anatomical and Clinical Pathology at Loyola University Medical Center (2018) Fellowship in Uropathology at New York University Langone Health (2019) Fellowship in Cytopathology at Memorial Sloan Kettering Cancer Center (2020) Board Certification in Anatomical and Clinical Pathology by The American Board of Pathology Dr. Isaila's research centers on diagnostic innovations in urologic pathology, with emphasis on digital pathology applications for gender-affirmation surgery specimens, renal neoplasms with lymphadenopathy patterns, and MRI-targeted prostate biopsy reporting. His work bridges surgical pathology with emerging imaging technologies to refine diagnostic criteria for complex urologic conditions. Analysis of his 2018-2025 publications reveals progressive integration of digital pathology in gender-affirmation care, novel characterization of renal tumor-lymph node interactions, and standardization of prostate cancer grading protocols. Key thematic threads include transplant-related malignancy mechanisms and optimization of pathology reporting for image-guided interventions. No scientific awards were documented in the provided profile. The profile contains no information regarding student mentorship or research grant funding. Departmental affiliations focus within Pathology's Genitourinary and Soft Tissue subspecialty divisions without specific laboratory team references.

Carrie L. LangstraatView profile

Professor

• Gynecologic Oncology
• Ovarian Cancer Treatment
• Artificial Intelligence in Ultrasound
• +6 more

Dr. Carrie Langstraat is a Professor of Obstetrics and Gynecology at Mayo Clinic College of Medicine and a fellowship-trained Gynecologic Oncologist specializing in the surgical treatment of patients with gynecologic cancers or increased cancer risk. She serves as the Gynecologic Oncology Fellowship director at Mayo Clinic in Rochester and is board certified in both Obstetrics and Gynecology and Gynecologic Oncology. Her clinical expertise encompasses comprehensive gynecologic cancer care including treatment of ovarian, fallopian tube, primary peritoneal, uterine, cervical, vaginal, and vulvar cancers. She specializes in complex surgical procedures for gynecologic malignancies, fertility preservation, cancer risk reduction in BRCA carriers and Lynch syndrome patients, and surgical management of extensive endometriosis as part of a multidisciplinary team. Dr. Langstraat's research focuses on optimizing surgical outcomes in ovarian cancer treatment and applying artificial intelligence to better characterize ovarian masses. Her recent publications (2021-2025) demonstrate expertise in gynecologic oncology, surgical techniques, AI applications in diagnostics, and quality of life outcomes following complex cancer treatments. Her work spans clinical trials, surgical innovation, and translational research with significant contributions to understanding endometrial cancer management and vulvar/vaginal melanoma outcomes. National Ovarian Cancer Coalition Early Detection Research Grant (2023) Multiple 'Best Doctors for Women' awards from Minnesota Monthly Magazine (2017-2020) Charles S. Field Award for excellence in education (2018) Roy M. Pitkin Award from ACOG & Elsevier Science (2016) Multiple Golden Apple Awards for Medical Student Teaching (2004, 2005) As an educator, Dr. Langstraat mentors residents, fellows, and medical students while serving in leadership roles including Co-Chair of the SGO Program Director Network and Board Examiner for the American Board of Obstetrics and Gynecology. Her professional activities reflect deep engagement with the Society of Gynecologic Oncologists, International Gynecologic Cancer Society, and Accreditation Council for Graduate Medical Education.

Traci FoxView profile

Associate Professor

• Subharmonic imaging
• Photoacoustic research
• Sentinel lymph nodes
• +8 more

Traci Fox serves as Associate Professor and Program Director for Diagnostic Medical Sonography at Thomas Jefferson University's Sidney Kimmel Medical College, Department of Radiology. She maintains clinical certifications through the American Registry for Diagnostic Medical Sonography (ARDMS) in abdomen, obstetrics/gynecology, breast, and vascular specialties, and holds ARRT certification in radiography. Her educational background includes: EdD from Drexel University (2014) MS from Thomas Jefferson University (2007) BS from Thomas Jefferson University (1993) Dr. Fox's research centers on innovative ultrasound applications, with primary focus on subharmonic imaging/SHAPE techniques and photoacoustic research for early cancer detection. She investigates sentinel lymph node mapping in pancreatic and breast cancer, developing sonographic protocols for tumor characterization and treatment monitoring. Her work bridges advanced imaging physics with clinical oncology applications. Her publication portfolio demonstrates consistent contributions to diagnostic sonography, with recurring themes in vascular abnormalities, cancer imaging, and educational methodologies. Key trends include translational research from animal models to clinical practice, vascular pathology case documentation, and distance education innovations for sonography training programs. Professional recognition includes: Fellow of the Society for Vascular Ultrasound (FSVU) Senior Member status in the American Institute of Ultrasound in Medicine As Program Director, Dr. Fox oversees curriculum development and student training in diagnostic medical sonography while maintaining active hospital appointments. Her professional society affiliations drive national standards development in ultrasound education and clinical practice, though specific grant details are not provided in source materials. She maintains active roles in seven professional organizations including the Society of Diagnostic Medical Sonographers, Society for Vascular Ultrasound, and Association of Educators in Imaging and Radiologic Sciences, contributing to committees focused on vascular imaging standards and educational accreditation.

• Nuclear Medicine
• Thyroid Cancer Imaging
• PET/CT Diagnostics
• +4 more

Funda ÜSTÜN is a Professor at Trakya University Medical Faculty's Department of Nuclear Medicine with extensive expertise in molecular imaging applications for cancer diagnostics and therapy. Her clinical and research focus centers on thyroid cancer imaging, prostate cancer diagnostics using PSMA-targeted radiopharmaceuticals, and sarcoma research. Her research interests span Nuclear Medicine, Thyroid Cancer Imaging, PET/CT Diagnostics, Prostate Cancer Imaging, Radiopharmaceutical Development, Sarcoma Research, and Molecular Imaging. She investigates advanced imaging techniques for cancer characterization, develops novel radiopharmaceuticals for targeted therapy, and applies machine learning to improve cancer risk stratification. Her work bridges nuclear medicine with oncology, endocrinology, and nanotechnology to enhance diagnostic accuracy and therapeutic outcomes. Her recent publications demonstrate strong trends in precision oncology, with emphasis on PSMA imaging for prostate cancer, thyroid cancer recurrence prediction using AI, and nanoparticle-based drug delivery systems. Key research areas include radiopharmaceutical development, molecular imaging biomarkers, and quantitative imaging analysis for tumor characterization. As an academic advisor, she has supervised multiple master's theses focusing on PET/CT applications in prostate cancer, lung metastasis prediction, and parathyroid scintigraphy. Her editorial and referee work includes contributions to MIRT (Molecular Imaging and Radiotherapy). Her laboratory and research team focus on preclinical radiopharmaceutical development, molecular imaging techniques, and translational applications of nuclear medicine in oncology. Current projects involve nanoparticle-based drug delivery systems, radiolabeling techniques, and advanced PET/CT quantification methods for cancer diagnostics.

• Hematology
• Lymphoma Research
• Pathology
• +3 more

Lise Mette Rahbek Gjerdrum is a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen, specializing in Pathology with a focus on hematological malignancies. She maintains an active research program with significant contributions to the understanding of lymphoma subtypes and Waldenström macroglobulinemia. Research Focus: Specializes in hematopathology with emphasis on lymphoma classification and molecular characterization Conducts population-based studies on rare hematological malignancies Investigates molecular mechanisms of therapy resistance in B-cell lymphomas Examines proteomic and mutational landscapes in blood cancers Recent Publication Trends: Her research output demonstrates a consistent focus on Waldenström macroglobulinemia, with multiple population-based studies examining central nervous system involvement, extramedullary disease patterns, and mutational landscapes. Recent work also explores NOTCH1 mutations in therapy resistance and proteomic analyses of melanoma subtypes. Affiliations: Department of Clinical Medicine, University of Copenhagen Pathology Department, Region Sjaelland Collaborations: Maintains extensive collaborations with hematologists and pathologists across Denmark, particularly with researchers at Region Sjaelland including Østergaard, Munksgaard, and Hammer. Frequently collaborates on nationwide cohort studies of rare lymphomas.

• Endoscopic ultrasound
• Endobronchial ultrasound
• Gastroenterology
• +6 more

Peter Vilmann is a Clinical Professor at the Department of Clinical Medicine, University of Copenhagen, where he has been a Full Professor of Endoscopy at Copenhagen University Hospital Herlev since 2010. He leads an Excellence Center for EUS (Endoscopic Ultrasound) and CLE (Confocal Laser Endomicroscopy) in Europe, which became operational in September 2012. His academic journey includes training at various Danish hospitals (1982-1993), positions at Herlev Hospital and Rigshospitalet, and a long tenure at Gentofte Hospital where he served as Overlæge (1995-2009) and Scientific Lecturer (2005-2010). MD (cand.med), University of Copenhagen (1981) Specialization in Gastroenterology (1994) and Surgery (1993), University of Copenhagen MD.Sc (dr.med A-disputats), University of Copenhagen (1998) Honoris Causa, University of Medicine and Pharmacy Craiova, Romania (2011) Professor Vilmann pioneered EUS with linear transducers and was the first in the world to perform EUS-guided fine needle biopsy (1991). His research focuses on advanced endoscopic techniques including EUS, EBUS, NOTES, CLE, and EUS-guided therapeutic interventions. He has made significant contributions to EUS-FNA procedures, EUS-guided pseudocyst drainage, bile duct drainage, and non-anesthesiologist propofol sedation (NAPS) programs. His work bridges diagnostic and therapeutic applications in gastrointestinal endoscopy with particular emphasis on pancreatic and biliary interventions. His recent publications (2023-2025) demonstrate continued innovation in pancreatic tumor ablation, virtual reality for colonoscopy training, advanced sedation techniques, and the integration of EUS with novel imaging technologies. The research consistently focuses on improving diagnostic accuracy, procedural safety, and developing minimally invasive alternatives to surgery for gastrointestinal conditions. Scientific Recognition: The Swedish Society of Medicine Jubileumspriset (1999) Copenhagen county employee Idea Prize (2005) Doctor Honoris Causa from University of Medicine and Pharmacy Craiova, Romania (2009) Primary Doctors at Gentofte Hospital Honorary award (2011) Visiting Professorship in Chandigarh, India (2011) Herlev Hospitals High Impact prize (2011) Professor Vilmann has secured substantial research funding including grants from The A.P. Møller and Chastine Mc-Kinney Møller Foundation ($387,045), Arvid Nilssons Foundation ($324,875), Toyota Foundation ($63,170), The Jochum Foundation ($90,243), and Aase and Ejnar Danielsen Foundation ($27,073). He serves on editorial boards for several prestigious journals including Endoscopy and Endoscopic Ultrasound, and has been instrumental in developing guidelines through the European Society of Gastrointestinal Endoscopy (ESGE) Guideline Committee. His endoscopy center at Herlev Hospital functions as a clinical and translational research environment with state-of-the-art equipment for EUS and CLE. The center supports numerous international multicentric studies including research on EUS-guided gallbladder drainage, needle-based CLE for pancreatic masses, and characterization of Crohn's disease using CLE technology.

• Hematology
• Lymphangiogenesis
• Cytokine Research
• +3 more

Troels Hammer serves as a Clinical Associate Professor at the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. His clinical specialization lies in Internal Medicine: Haematology at Copenhagen University Hospital (Region H). His research focuses on inflammatory cytokines and their lymphangiogenic activities, particularly examining interleukin-20 (IL-20), IL-7, IL-23, and IL-27 effects on lymphatic endothelial cells. His primary research interests span hematology, lymphangiogenesis, and cytokine biology. Current work investigates inflammatory cytokine interactions with lymphatic endothelium using immortalized cell lines (hTERT-HDLEC). His publication history reveals a strong focus on Waldenström macroglobulinemia, including studies on central nervous system involvement, extramedullary disease, mutational landscapes, and nodal involvement impacts. Earlier work explored dietary risk factors in inflammatory bowel diseases and osteoporosis risks following lymphoma treatments. His 11 research outputs (2013-2025) demonstrate consistent contributions to hematology and immunology. Key trends include population-based studies on rare lymphoproliferative disorders, molecular characterization of Waldenström macroglobulinemia, and translational cytokine research. His 2025 study on Bing-Neel syndrome represents cutting-edge clinical hematology research. Hammer maintains active clinical and research roles with no documented scientific awards listed in the provided materials. His collaborative network includes researchers across Danish hospitals and international institutions, evidenced by multi-center studies. He has contributed to policy-relevant research, particularly in inflammatory bowel disease where his work has been referenced in policy sources. His educational background includes a medical degree (Cand. med.) from the University of Copenhagen (2005), followed by clinical training and PhD studies at Panum Institute. Early research experience includes work on multidrug resistance phenotypes, post-exercise lipolysis, and growth hormone roles in Jens Bülows' laboratory. He has served as an instructor at the Danish Institute for Medical Simulation (DIMS) and taught physiology to medical students.